Abstract
Mediterranean Journal of Rheumatology March 2020 Highlights.
Highlights
We are witnessing a global pandemic that has hitherto killed more than 30,000 people worldwide, and the number of confirmed cases has reached to date almost 660,000
This proposal tackles important aspects of COVID-19 in relation to rheumatic disease, such as, whether patients with rheumatic diseases are a ‘’vulnerable group’’, what is the risk of a serious outcome of the infection for patients receiving anti-rheumatic treatment, and what should patients with rheumatic disease who receive anti-rheumatic treatment do
It is known that Anti-melanoma differentiation associated gene 5 autoantibodies are associated with amyopathic dermatomyositis and in particular with rapidly progressive interstitial lung disease
Summary
We are witnessing a global pandemic that has hitherto killed more than 30,000 people worldwide, and the number of confirmed cases has reached to date almost 660,000. The official statement of the Greek Rheumatology Society and Professional Association of Rheumatologists An interesting article by Bogdanos et al.[17] discusses whether hydroxychloroquine, a drug that rheumatologists and their patients know very well and use routinely for decades, could be part of our armamentarium against
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
